Heartflow, Inc. (NASDAQ:HTFL) Short Interest Update

Heartflow, Inc. (NASDAQ:HTFL) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 3,162,641 shares, an increase of 118.3% from the December 15th total of 1,448,787 shares. Based on an average trading volume of 1,033,532 shares, the short-interest ratio is currently 3.1 days. Currently, 3.7% of the shares of the company are short sold. Currently, 3.7% of the shares of the company are short sold. Based on an average trading volume of 1,033,532 shares, the short-interest ratio is currently 3.1 days.

Heartflow Stock Up 5.3%

NASDAQ:HTFL traded up $1.69 on Wednesday, hitting $33.76. The company had a trading volume of 572,471 shares, compared to its average volume of 724,586. Heartflow has a 52 week low of $25.38 and a 52 week high of $41.22. The stock has a market cap of $2.88 billion and a PE ratio of -18.65. The company’s 50 day moving average price is $30.13.

Analysts Set New Price Targets

Several analysts have weighed in on HTFL shares. JPMorgan Chase & Co. lifted their price objective on shares of Heartflow from $36.00 to $40.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Canaccord Genuity Group raised their target price on shares of Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a report on Thursday, November 13th. Stifel Nicolaus boosted their price target on Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a research note on Thursday, November 13th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Heartflow in a research note on Monday, December 29th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Heartflow currently has a consensus rating of “Hold” and an average target price of $38.60.

Insider Transactions at Heartflow

In other news, Director Jeffrey C. Lightcap acquired 40,000 shares of the firm’s stock in a transaction on Tuesday, December 16th. The shares were purchased at an average cost of $26.34 per share, with a total value of $1,053,600.00. Following the acquisition, the director directly owned 40,000 shares in the company, valued at $1,053,600. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through this link.

Hedge Funds Weigh In On Heartflow

A number of institutional investors and hedge funds have recently bought and sold shares of the company. TFC Financial Management Inc. bought a new position in Heartflow in the third quarter valued at about $40,000. Legal & General Group Plc bought a new position in Heartflow in the 3rd quarter valued at approximately $59,000. Y Intercept Hong Kong Ltd bought a new stake in Heartflow during the 3rd quarter worth approximately $234,000. Legato Capital Management LLC acquired a new position in Heartflow in the 3rd quarter valued at approximately $243,000. Finally, Sandia Investment Management LP bought a new position in shares of Heartflow during the third quarter valued at $252,000.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.